ABA Chemicals Corp (300261) – aksjekurser og nyheter

ABA Chemicals, also known as Abachem, is a Chinese chemical manufacturing company headquartered in Taicang. The company was founded in 2006 as Suzhou ABA Chemicals, and is traded on the Shenzhen Stock Exchange as 300261. The company provides contract development and manufacturing services to the pharmaceutical, biotechnological, and agrochemical industries. It offers various services for the production of fine chemicals; intermediates; and active pharmaceutical ingredients. The company also provides unnatural amino acids, pyrazoles, triazoles, and azaindoles, as well as producing an intermediate of API Levetiracetam for the treatment of epilepsy. The company is also involved in pesticide manufacturing intermediates, and acquired the Chinese firm Shanghai Puyi Chemical to consolidate its position in this market. It also acquired Amino Chemicals, a pharmaceutical API intermediate manufacturer and member of the Dipharma Group, in 2017; Amino is based on Malta and was established in 1992. ABA and Dipharma began a working partnership in the 1980s, which provided Dipharma access to the Chinese pharmaceutical market. Wikipedia

Om ABA Chemicals Corp

Administrerende direktør-

Ansatte1,2k

Grunnlagt13. jan. 2006

Hovedkontor-

SektorSpeciality chemicals

Nettstedabachem.com

Alle verdier i CNY	sep. 2025	des. 2025	mars 2026	juni 2026
Inntekt	334,69 mill.	310,82 mill.	303,59 mill.	293,25 mill.
Varekostnad	248,45 mill.	300,89 mill.	286,91 mill.	289,14 mill.
Direkte driftskostnader	248,45 mill.	300,89 mill.	286,91 mill.	289,14 mill.
Utgifter til forskning og utvikling	29,18 mill.	28,68 mill.	20,19 mill.	22,86 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	48,48 mill.	37,47 mill.	41,02 mill.	41,59 mill.
Driftskostnader	81,42 mill.	103,89 mill.	62,77 mill.	66,53 mill.
Totale driftskostnader	329,87 mill.	404,78 mill.	349,68 mill.	355,67 mill.
Driftsinntekter	4,82 mill.	−93,96 mill.	−46,09 mill.	−62,42 mill.
Andre ikke-operasjonelle inntekter	15,52 mill.	−16,13 mill.	−10,85 mill.	9,81 mill.
EBT inkludert uvanlige elementer	−2,79 mill.	−177,93 mill.	−73,15 mill.	−115,16 mill.
EBT uten uvanlige elementer	−1,61 mill.	−124,19 mill.	−66,74 mill.	−83,81 mill.
Kostnad for inntektsskatt	−3,44 mill.	−6,13 mill.	−14,24 mill.	−13,04 mill.
Faktisk avgiftssats	123,57 %	3,45 %	19,47 %	11,32 %
Andre driftskostnader	2,79 mill.	−849,91k	2,71 mill.	3,05 mill.
Nettoinntekt	1,75 mill.	−152,59 mill.	−57,58 mill.	−101,81 mill.
Netto fortjenestemargin	0,52 %	−49,09 %	−18,97 %	−34,72 %
Resultat per aksje	-	-	-	-
Rente- og investeringsinntekter	5,04 mill.	-	568,87k	77,43k
Rentekostnader	−9,72 mill.	−15,90 mill.	−10,37 mill.	−13,65 mill.
Netto rentekostnader	−4,68 mill.	−15,90 mill.	−9,80 mill.	−13,58 mill.
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	38,18 mill.	−59,20 mill.	−11,33 mill.	−28,50 mill.
Gevinst eller tap ved salg av eiendeler	110,13k	−161,52k	-	−258,93k

Finance

Spør om hva som helst